US equities |
MU $856.49 ▲+0.00% SNDK $1,260.93 ▲+0.00% SPCX $144.75 ▲+0.00% ELME $1.77 ▲+0.00% NVDA $212.21 ▲+0.00% BE $217.77 ▲+0.00% SKHY $131.69 ▲+0.00% TSLA $374.57 ▼-0.00%
FinancialContent

Articles published by Opiant Pharmaceuticals, Inc.

News headline image
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
From Opiant Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers OPNT
News headline image
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
From Opiant Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers OPNT
News headline image
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
From Opiant Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers OPNT